Feb 21, 2024
143:140
For every 140 shares held, investors received 143. The price per share adjusted from $0.11 to $0.11.
The split itself did not change the total investment value.
Rhythm Biosciences Limited (ASX:RHY) operates in the Medical specialties industry.
Rhythm Biosciences Limited company overviewRhythm Biosciences Limited's most recent stock split was on February 21, 2024. It was a 143-for-140 forward split, so shareholders received 143 shares for every 140 they held.
Rhythm Biosciences Limited (ASX:RHY) has split its stock 2 times: a 8-for-7 split on July 27, 2020 and a 143-for-140 split on February 21, 2024.
Rhythm Biosciences Limited has split its stock 2 times. This history records 2 forward splits between July 27, 2020 and February 21, 2024.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Rhythm Biosciences Limited's 143-for-140 split on February 21, 2024, every 140 shares became 143 shares.
Rhythm Biosciences Limited has not announced a new split in our records. Its most recent split was on February 21, 2024, 2 years ago. Companies announce splits in advance, and any new ASX:RHY split will appear on this page.
Already premium?